Arcutis Biotherapeutics, Inc.

NASDAQ:ARQT

14.81 (USD) • At close March 13, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 71.3644.75530.85849.56913.52638.1095.192.7812.9610.725000000000000000000
Kosten van de omzet 6.9055.5033.4643.2562.4441.1820.7760.7830.4850.2690.2340.2290.2110.1920.1820.1780.1660021.9900000000
Brutowinst 64.45539.25227.39446.31311.08236.9274.4141.9982.4760.456-0.234-0.229-0.211-0.192-0.182-0.178-0.16600-21.9900000000
Brutowinstmarge 0.9030.8770.8880.9340.8190.9690.850.7180.8360.629000000000000000000
Onderzoek- en ontwikkelingskosten 14.4819.50119.29823.14123.77526.23625.21935.34533.87769.73138.20540.62252.55840.60430.76521.63127.37432.74330.00925.18210.75712.3487.2146.2035.3477.0812.7562.756
Algemene en administratieve kosten 0000136.47147.59545.9585.79149.62835.47327.62222.00618.72816.47411.31514.4546.695.565.6183.4692.2372.31.3240.7490.6060.6140.2880.288
Verkoop- en marketingkosten 0000-87.9950037.127-12.6050000000000000000000
Verkoop-, algemene en administratieve kosten 57.60758.81758.17354.79448.47647.59545.95842.91837.02335.47327.62222.00618.72816.47411.31514.4546.695.565.6183.4692.2372.31.3240.7490.6060.6140.2880.288
Overige kosten 005.2294.0442.6722.7213.1213.2073.321.9380.4210.142-0.040.0980.0720.0430.0150.0990.2150.6380.4260.1680.2480.2940.352000
Bedrijfskosten 72.08778.31877.47177.93572.25173.83171.17778.26370.9105.20465.82762.62871.28657.07842.0836.08534.06438.30335.62728.65112.99414.6488.5386.9525.9537.6423.0063.006
Bedrijfsresultaat -7.632-39.066-50.077-31.622-61.169-36.904-66.763-76.265-68.424-104.748-65.827-62.628-71.286-57.078-42.08-36.085-34.064-38.303-35.627-28.651-12.994-14.648-8.538-6.952-5.953-7.695-3.044-3.044
Bedrijfsresultaat ratio -0.107-0.873-1.623-0.638-4.522-0.968-12.864-27.424-23.108-144.48000000000000000000
Totaal overige inkomsten en kosten netto -2.833-2.471-2.255-3.436-5.09-4.838-4.228-3.835-3.595-2.961-1.579-1.696-0.040.0980.0720.0430.0150.0990.2150.6380.4260.1680.2480.2940.3520.020.0540.054
Inkomen voor belasting -10.465-41.537-52.332-35.058-66.259-41.742-70.991-80.1-72.019-107.709-67.406-64.324-71.326-56.98-42.008-36.042-34.049-38.204-35.412-28.013-12.568-14.48-8.29-6.658-5.601-7.675-2.99-2.99
Inkomen voor belasting ratio -0.147-0.928-1.696-0.707-4.899-1.095-13.678-28.803-24.323-148.564000000000000000000
Belastingkosten 0.323000.3240.0253.02310.084-0.3633.5952.9611.5791.696-0.136-0.076-0.078-0.098-0.13100.00800000-5.9530.020.0540.054
Nettowinst -10.788-41.537-52.332-35.382-66.284-44.765-70.991-79.737-75.614-110.67-68.985-66.02-71.326-56.98-42.008-36.042-34.049-38.204-35.412-28.013-12.568-14.48-8.29-6.658-5.601-7.675-2.99-2.99
Nettowinstmarge -0.151-0.928-1.696-0.714-4.9-1.175-13.678-28.672-25.537-152.648000000000000000000
WPA (Winst Per Aandeel) -0.089-0.33-0.42-0.32-0.72-0.73-1.16-1.3-1.24-1.94-1.34-1.31-1.42-1.14-0.84-0.76-0.792-1.01-0.94-0.74-0.33-0.4-0.218-0.175-0.155-0.212-2.83-2.83
Verwaterde WPA -0.089-0.33-0.42-0.32-0.72-0.73-1.16-1.3-1.24-1.94-1.34-1.31-1.42-1.14-0.84-0.76-0.792-1.01-0.94-0.74-0.33-0.4-0.218-0.175-0.155-0.212-2.83-2.83
EBITDA -4.456-33.452-44.497-27.22-58.112-33.796-63.168-72.695-64.675-102.574-65.172-62.257-71.115-56.788-41.826-35.864-34.029-38.273-35.597-28.624-13.038-14.629-8.518-6.94700.020.0540.054
EBITDA ratio -0.062-0.747-1.611-0.631-4.494-0.897-12.262-26.27-21.987-141.418000000000000000000